# INSMED Inc: filings

INSM · Nasdaq · CIK 1104506 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/insm.md) · [Financials](/companies/insm/financials.md) · [Filings](/companies/insm/filings.md) · [Insiders](/companies/insm/insiders.md)

## Reports and events: 362 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 648, 8-K 262, 144 226, SC 13G/A 78, 10-Q 54, 3 38, 424B5 23, DEF 14A 23, SC 13G 20, 10-K 18, DEFA14A 13, S-8 13, SCHEDULE 13G/A 12, CT ORDER 11, UPLOAD 7, ARS 5, S-3ASR 5, CORRESP 4, FWP 4, 424B2 3, 5 3, 8-K/A 3, 3/A 2, 4/A 2, EFFECT 2, PRE 14A 2, S-3 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, D 1, POSASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:01 ET | [8-K](/filings/0001140361-26-041097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-041097 |
| 2026-10-29 | 07:00 ET | [10-Q](/filings/0001104506-26-000047.md) | Quarterly report, period 2026-09-30 | 0001104506-26-000047 |
| 2026-10-20 | 07:00 ET | [8-K](/filings/0001140361-26-040177.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-040177 |
| 2026-10-05 | 07:01 ET | [8-K](/filings/0001140361-26-038529.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038529 |
| 2026-08-06 | 07:00 ET | [8-K](/filings/0001140361-26-031502.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-031502 |
| 2026-08-06 | 06:59 ET | [10-Q](/filings/0001104506-26-000041.md) | Quarterly report, period 2026-06-30 | 0001104506-26-000041 |
| 2026-07-16 | 07:00 ET | [8-K](/filings/0001140361-26-028602.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-028602 |
| 2026-05-15 | 16:01 ET | [8-K](/filings/0001140361-26-021648.md) | 5.07 Shareholder vote results | 0001140361-26-021648 |
| 2026-05-07 | 07:01 ET | [8-K](/filings/0001140361-26-019430.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019430 |
| 2026-05-07 | 07:00 ET | [10-Q](/filings/0001104506-26-000032.md) | Quarterly report, period 2026-03-31 | 0001104506-26-000032 |
| 2026-04-07 | 16:01 ET | [8-K](/filings/0001140361-26-013659.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-013659 |
| 2026-04-01 | 16:01 ET | [DEF 14A](/filings/0001104506-26-000022.md) | Proxy statement, period 2026-05-13 | 0001104506-26-000022 |
| 2026-03-23 | 07:00 ET | [8-K](/filings/0001140361-26-010651.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-010651 |
| 2026-02-19 | 07:01 ET | [10-K](/filings/0001104506-26-000009.md) | Annual report, period 2025-12-31 | 0001104506-26-000009 |
| 2026-02-19 | 07:01 ET | [8-K](/filings/0001140361-26-006116.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-006116 |
| 2026-01-09 | 07:01 ET | [8-K](/filings/0001140361-26-000778.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000778 |
| 2025-12-17 | 16:02 ET | [8-K](/filings/0001140361-25-045836.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-045836 |
| 2025-11-18 | 16:15 ET | [8-K](/filings/0001140361-25-042598.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-042598 |
| 2025-10-30 | 07:00 ET | [10-Q](/filings/0001104506-25-000053.md) | Quarterly report, period 2025-09-30 | 0001104506-25-000053 |
| 2025-10-30 | 07:00 ET | [8-K](/filings/0001140361-25-039789.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-039789 |
| 2025-08-12 | 11:55 ET | [8-K](/filings/0001140361-25-030537.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-030537 |
| 2025-08-07 | 07:01 ET | [8-K](/filings/0001140361-25-029343.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-029343 |
| 2025-08-07 | 07:01 ET | [10-Q](/filings/0001104506-25-000043.md) | Quarterly report, period 2025-06-30 | 0001104506-25-000043 |
| 2025-06-13 | 08:21 ET | [8-K](/filings/0001140361-25-022375.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-022375 |
| 2025-06-10 | 07:00 ET | [8-K](/filings/0001140361-25-022023.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-022023 |
| 2025-06-06 | 17:00 ET | [8-K](/filings/0001140361-25-021810.md) | 8.01 Other events | 0001140361-25-021810 |
| 2025-05-16 | 16:37 ET | [8-K](/filings/0001140361-25-019490.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001140361-25-019490 |
| 2025-05-08 | 07:00 ET | [8-K](/filings/0001140361-25-017858.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017858 |
| 2025-05-08 | 06:59 ET | [10-Q](/filings/0001104506-25-000026.md) | Quarterly report, period 2025-03-31 | 0001104506-25-000026 |
| 2025-04-24 | 17:09 ET | [8-K/A](/filings/0001140361-25-015487.md) | 8.01 Other events | 0001140361-25-015487 |
| 2025-04-24 | 07:00 ET | [8-K](/filings/0001140361-25-015301.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-015301 |
| 2025-04-17 | 16:02 ET | [8-K](/filings/0001140361-25-014376.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-014376 |
| 2025-04-04 | 08:15 ET | [DEF 14A](/filings/0001104506-25-000018.md) | Proxy statement, period 2025-05-15 | 0001104506-25-000018 |
| 2025-02-24 | 08:00 ET | [8-K](/filings/0001140361-25-005570.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-005570 |
| 2025-02-20 | 07:00 ET | [8-K](/filings/0001140361-25-005190.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005190 |
| 2025-02-20 | 07:00 ET | [10-K](/filings/0001104506-25-000009.md) | Annual report, period 2024-12-31 | 0001104506-25-000009 |
| 2025-02-06 | 08:00 ET | [8-K](/filings/0001140361-25-003266.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-003266 |
| 2025-01-10 | 08:00 ET | [8-K](/filings/0001140361-25-000711.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000711 |
| 2024-11-19 | 08:00 ET | [8-K](/filings/0001140361-24-047246.md) | 1.02 Termination of a material agreement | 0001140361-24-047246 |
| 2024-10-31 | 07:00 ET | [8-K](/filings/0001140361-24-044703.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-044703 |
| 2024-10-31 | 07:00 ET | [10-Q](/filings/0001104506-24-000033.md) | Quarterly report, period 2024-09-30 | 0001104506-24-000033 |
| 2024-08-09 | 17:30 ET | [8-K](/filings/0001140361-24-036671.md) | 8.01 Other events | 0001140361-24-036671 |
| 2024-08-08 | 07:00 ET | [8-K](/filings/0001140361-24-036279.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036279 |
| 2024-08-08 | 07:00 ET | [10-Q](/filings/0001104506-24-000026.md) | Quarterly report, period 2024-06-30 | 0001104506-24-000026 |
| 2024-07-03 | 09:00 ET | [8-K](/filings/0001140361-24-032333.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-032333 |
| 2024-06-27 | 08:05 ET | [8-K](/filings/0001140361-24-031492.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-031492 |
| 2024-06-13 | 08:00 ET | [8-K](/filings/0001140361-24-029955.md) | 8.01 Other events | 0001140361-24-029955 |
| 2024-06-04 | 07:00 ET | [8-K](/filings/0001140361-24-028710.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-028710 |
| 2024-05-30 | 17:32 ET | [8-K](/filings/0001140361-24-028205.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-028205 |
| 2024-05-28 | 06:30 ET | [8-K](/filings/0001140361-24-027535.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-027535 |

Page 1 of 8. [Older](/companies/insm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:15 ET. No prices; not investment advice.